Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
The Epidemiologic Evidence Linking Autoimmune Diseases and Psychosis.
Milder multiple sclerosis course in patients with concomitant inflammatory bowel disease.
Quality of life and cognitive functions in early onset multiple sclerosis.
Prevalence and risk factors for depression in women with multiple sclerosis: a study from Iran.
[Blood and cerebrospinal fluid test in multiple sclerosis].
N-Acetylaspartate Synthase Deficiency Corrects the Myelin Phenotype in a Canavan Disease Mouse Model But Does Not Affect Survival Time.
Mechanisms of sodium channel clustering and its influence on axonal impulse conduction.
Best Practices for Network Meta-Analysis Methodology: Comparative Effectiveness of Interferon-Beta Therapies In Relapsing-Remitting Multiple Sclerosis.
Remyelination of the Corpus Callosum by Olfactory Ensheathing Cell in an Experimental Model of Multiple Sclerosis.
Reduced cortical microvascular oxygenation in multiple sclerosis: a blinded, case-controlled study using a novel quantitative near-infrared spectroscopy method.
Acute optic neuritis: a clinical paradigm for evaluation of neuroprotective and restorative strategies?
Heme oxygenase-1 is dispensable for the anti-inflammatory activity of intravenous immunoglobulin.
Mycophenolate mofetil in combination with interferon beta-1a in the treatment of relapsing-remitting multiple sclerosis: A preliminary study.
Development of oral agent in the treatment of multiple sclerosis: how the first available oral therapy, fingolimod will change therapeutic paradigm approach.
Citrullination of TNF-α by peptidylarginine deiminases reduces its capacity to stimulate the production of inflammatory chemokines.
Assessment of prevalence and pathological response to orthostatic provocation in patients with multiple sclerosis.
Inflammatory demyelinating central nervous system diseases in childhood: clinical and paraclinical profiles in 133 patients.
Correlation between blink reflex abnormalities and magnetic resonance imaging findings in patients with multiple sclerosis.
Persistent visual impairment in multiple sclerosis: prevalence, mechanisms and resulting disability.
Erythropoietin Levels in Patients with Multiple SclerosisComplicated with Anemia.
[Research status on the epidemiological characteristics of optic neuritis].
Combining clinical and magnetic resonance imaging markers enhances prediction of 12-year disability in multiple sclerosis.
The development of chronic inflammatory demyelinating polyneuropathy during adalimumab treatment in a patient with psoriasis vulgaris.
Sjögren's syndrome and multiple sclerosis: Two sides of the same coin?
The Cannabinoid CB1/CB2 Agonist WIN55212.2 Promotes Oligodendrocyte Differentiation In Vitro and Neuroprotection During the Cuprizone-Induced Central Nervous System Demyelination.
Pages
« first
‹ previous
…
560
561
562
563
564
565
566
567
568
…
next ›
last »